Combination Therapy of ReciGen Interferon, Methylprednisolone, and Sovodak as a Candidate for Treatment of Patients With Severe COVID-19 in Iran: A Case Series

Zahra Kamiab; Ali Esmaeili Nadimi; Fatemeh Bahrehmand

Volume 7, Issue 1 , February 2022, , Pages 33-36

http://dx.doi.org/10.34172/hpr.2022.07

Abstract
  Introduction: During the current worldwide pandemic of coronavirus disease 2019 (CPVID-19), this disease was first identified in Iran at the end of February. This study was conducted to examine patients with severe COVID-19 disease, who were treated with three medications, namely ReciGen, methylprednisolone, ...  Read More